Diabetes 51:2734-2741, 2002
© 2002 by the American Diabetes Association, Inc.
Androgens Decrease Plasma Adiponectin, an Insulin-Sensitizing Adipocyte-Derived Protein
Hitoshi Nishizawa,
Iichiro Shimomura,
Ken Kishida,
Norikazu Maeda,
Hiroshi Kuriyama,
Hiroyuki Nagaretani,
Morihiro Matsuda,
Hidehiko Kondo,
Naoki Furuyama,
Shinji Kihara,
Tadashi Nakamura,
Yoshihiro Tochino,
Tohru Funahashi, and
Yuji Matsuzawa
From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Suita, Japan
Adiponectin, an adipose-specific secretory protein, exhibits antidiabetic and antiatherogenic properties. In the present study, we examined the effects of sex hormones on the regulation of adiponectin production. Plasma adiponectin concentrations were significantly lower in 442 men (age, 52.6 ± 11.9 years [mean ± SD]) than in 137 women (53.2 ± 12.0 years) but not different between pre- and postmenopausal women. In mice, ovariectomy did not alter plasma adiponectin levels. In contrast, high levels of plasma adiponectin were found in castrated mice. Testosterone treatment reduced plasma adiponectin concentration in both sham-operated and castrated mice. In 3T3-L1 adipocytes, testosterone reduced adiponectin secretion into the culture media, using pulse-chase study. Castration-induced increase in plasma adiponectin was associated with a significant improvement of insulin sensitivity. Our results indicate that androgens decrease plasma adiponectin and that androgen-induced hypoadiponectinemia may be related to the high risks of insulin resistance and atherosclerosis in men.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. N. Ealey, J. Kaludjerovic, M. C. Archer, and W. E. Ward
Adiponectin Is a Negative Regulator of Bone Mineral and Bone Strength in Growing Mice
Experimental Biology and Medicine,
December 1, 2008;
233(12):
1546 - 1553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Resmini, G. Andraghetti, A. Rebora, R. Cordera, L. Vera, M. Giusti, F. Minuto, and D. Ferone
Leptin, Ghrelin, and Adiponectin Evaluation in Transsexual Subjects During Hormonal Treatments
J Androl,
September 1, 2008;
29(5):
580 - 585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Caminos, R. Nogueiras, F. Gaytan, R. Pineda, C. R. Gonzalez, M. L. Barreiro, J. P. Castano, M. M. Malagon, L. Pinilla, J. Toppari, et al.
Novel Expression and Direct Effects of Adiponectin in the Rat Testis
Endocrinology,
July 1, 2008;
149(7):
3390 - 3402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Toth, B. C. Cooper, R. E. Pratley, A. Mari, D. E. Matthews, and P. R. Casson
Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion
Am J Physiol Endocrinol Metab,
June 1, 2008;
294(6):
E1035 - E1045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Moran, D. R. Jacobs Jr, J. Steinberger, L. M. Steffen, J. S. Pankow, C.-P. Hong, and A. R. Sinaiko
Changes in Insulin Resistance and Cardiovascular Risk During Adolescence: Establishment of Differential Risk in Males and Females
Circulation,
May 6, 2008;
117(18):
2361 - 2368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Atzmon, T. I. Pollin, J. Crandall, K. Tanner, C. B. Schechter, P. E. Scherer, M. Rincon, G. Siegel, M. Katz, R. B. Lipton, et al.
Adiponectin Levels and Genotype: A Potential Regulator of Life Span in Humans
J. Gerontol. A Biol. Sci. Med. Sci.,
May 1, 2008;
63(5):
447 - 453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Takahashi, S. Yamaguchi, T. Shimoyama, H. Seki, K. Miyokawa, H. Katsuta, T. Tanaka, K. Yoshimoto, H. Ohno, S. Nagamatsu, et al.
JNK- and I{kappa}B-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro
Am J Physiol Endocrinol Metab,
May 1, 2008;
294(5):
E898 - E909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nakagawa, K. Kishida, S. Kihara, M. Sonoda, A. Hirata, A. Yasui, H. Nishizawa, T. Nakamura, R. Yoshida, I. Shimomura, et al.
Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome
Am J Physiol Endocrinol Metab,
April 1, 2008;
294(4):
E778 - E784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-S. Youn, N. Kloting, J. Kratzsch, N. Lee, J. W. Park, E.-S. Song, K. Ruschke, A. Oberbach, M. Fasshauer, M. Stumvoll, et al.
Serum Vaspin Concentrations in Human Obesity and Type 2 Diabetes
Diabetes,
February 1, 2008;
57(2):
372 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Seeger, M. Ziegelmeier, A. Bachmann, U. Lossner, J. Kratzsch, M. Bluher, M. Stumvoll, and M. Fasshauer
Serum Levels of the Adipokine Vaspin in Relation to Metabolic and Renal Parameters
J. Clin. Endocrinol. Metab.,
January 1, 2008;
93(1):
247 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Maahs, L. G. Ogden, J. K. Snell-Bergeon, G. L. Kinney, R. P. Wadwa, J. E. Hokanson, D. Dabelea, A. Kretowski, R. H. Eckel, and M. Rewers
Determinants of Serum Adiponectin in Persons with and without Type 1 Diabetes
Am. J. Epidemiol.,
September 15, 2007;
166(6):
731 - 740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Barb, C. J Williams, A. K Neuwirth, and C. S Mantzoros
Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence
Am. J. Clinical Nutrition,
September 1, 2007;
86(3):
858S - 866S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Itoh, T. Suganami, N. Satoh, K. Tanimoto-Koyama, X. Yuan, M. Tanaka, H. Kawano, T. Yano, S. Aoe, M. Takeya, et al.
Increased Adiponectin Secretion by Highly Purified Eicosapentaenoic Acid in Rodent Models of Obesity and Human Obese Subjects
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2007;
27(9):
1918 - 1925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Moran, M. Noakes, P. M. Clifton, G. A. Wittert, D. P. Belobrajdic, and R. J. Norman
C-Reactive Protein before and after Weight Loss in Overweight Women with and without Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
August 1, 2007;
92(8):
2944 - 2951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. G. Hanley, D. Bowden, L. E. Wagenknecht, A. Balasubramanyam, C. Langfeld, M. F. Saad, J. I. Rotter, X. Guo, Y.-D. I. Chen, M. Bryer-Ash, et al.
Associations of Adiponectin with Body Fat Distribution and Insulin Sensitivity in Nondiabetic Hispanics and African-Americans
J. Clin. Endocrinol. Metab.,
July 1, 2007;
92(7):
2665 - 2671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Johnston, B. L. Beezhold, B. Mostow, and P. D. Swan
Plasma Vitamin C Is Inversely Related to Body Mass Index and Waist Circumference but Not to Plasma Adiponectin in Nonsmoking Adults
J. Nutr.,
July 1, 2007;
137(7):
1757 - 1762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Santosa, I. Demonty, A. H. Lichtenstein, K. Cianflone, and P. J.H. Jones
An Investigation of Hormone and Lipid Associations after Weight Loss in Women
J. Am. Coll. Nutr.,
June 1, 2007;
26(3):
250 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Kapoor, S Clarke, R Stanworth, K S Channer, and T H Jones
The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes
Eur. J. Endocrinol.,
May 1, 2007;
156(5):
595 - 602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Bullen Jr., S. Bluher, T. Kelesidis, and C. S. Mantzoros
Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice
Am J Physiol Endocrinol Metab,
April 1, 2007;
292(4):
E1079 - E1086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, B. Xia, C. Ma, Z. Hu, X. Chen, and P. Cao
Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China
Postgrad. Med. J.,
March 1, 2007;
83(977):
192 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Abbasi, H. M. F. Farin, C. Lamendola, T. McLaughlin, E. A. Schwartz, G. M. Reaven, and P. D. Reaven
The Relationship between Plasma Adiponectin Concentration and Insulin Resistance Is Altered in Smokers
J. Clin. Endocrinol. Metab.,
December 1, 2006;
91(12):
5002 - 5007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kanetsuna, K. Hirano, M. Nagata, M. A. Gannon, K. Takahashi, R. C. Harris, M. D. Breyer, and T. Takahashi
Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes
Am J Physiol Renal Physiol,
December 1, 2006;
291(6):
F1315 - F1322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M. Cho, B.-S. Youn, H. Lee, N. Lee, S.-S. Min, S. H. Kwak, H. K. Lee, and K. S. Park
Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.
Diabetes Care,
November 1, 2006;
29(11):
2457 - 2461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ledoux, D. B. Campos, F. L. Lopes, M. Dobias-Goff, M.-F. Palin, and B. D. Murphy
Adiponectin Induces Periovulatory Changes in Ovarian Follicular Cells
Endocrinology,
November 1, 2006;
147(11):
5178 - 5186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A Martos-Moreno, V. Barrios, and J. Argente
Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids
Eur. J. Endocrinol.,
September 1, 2006;
155(3):
429 - 434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Glintborg, M. Andersen, C. Hagen, J. Frystyk, V. Hulstrom, A. Flyvbjerg, and A. P. Hermann
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
Eur. J. Endocrinol.,
August 1, 2006;
155(2):
337 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-H. Gannage-Yared, S. Khalife, M. Semaan, F. Fares, S. Jambart, and G. Halaby
Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men.
Eur. J. Endocrinol.,
July 1, 2006;
155(1):
167 - 176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nakano, S. Tajima, A. Yoshimi, H. Akiyama, M. Tsushima, T. Tanioka, T. Negoro, M. Tomita, and T. Tobe
A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin
J. Lipid Res.,
July 1, 2006;
47(7):
1572 - 1582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Aso, R. Yamamoto, S. Wakabayashi, T. Uchida, K. Takayanagi, K. Takebayashi, T. Okuno, T. Inoue, K. Node, T. Tobe, et al.
Comparison of Serum High-Molecular Weight (HMW) Adiponectin With Total Adiponectin Concentrations in Type 2 Diabetic Patients With Coronary Artery Disease Using a Novel Enzyme-Linked Immunosorbent Assay to Detect HMW Adiponectin.
Diabetes,
July 1, 2006;
55(7):
1954 - 1960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Fraenkel, J Caloyeras, S-G Ren, and S Melmed
Sex-steroid milieu determines diabetes rescue in pttg-null mice.
J. Endocrinol.,
June 1, 2006;
189(3):
519 - 528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Punthakee, E. E. Delvin, J. O'Loughlin, G. Paradis, E. Levy, R. W. Platt, and M. Lambert
Adiponectin, Adiposity, and Insulin Resistance in Children and Adolescents
J. Clin. Endocrinol. Metab.,
June 1, 2006;
91(6):
2119 - 2125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Schalkwijk, N. Chaturvedi, M. T. Schram, J. H. Fuller, C. D. A. Stehouwer, and the EURODIAB Prospective Complications Study Group
Adiponectin Is Inversely Associated with Renal Function in Type 1 Diabetic Patients
J. Clin. Endocrinol. Metab.,
January 1, 2006;
91(1):
129 - 135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Iglseder, V. Mackevics, A. Stadlmayer, G. Tasch, G. Ladurner, and B. Paulweber
Plasma Adiponectin Levels and Sonographic Phenotypes of Subclinical Carotid Artery Atherosclerosis: Data From the SAPHIR Study
Stroke,
December 1, 2005;
36(12):
2577 - 2582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Mitchell, D T Armstrong, R L Robker, and R J Norman
Adipokines: implications for female fertility and obesity
Reproduction,
November 1, 2005;
130(5):
583 - 597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Otsuki, S. Kasayama, H. Saito, M. Mukai, and M. Koga
Sex Differences of Age-Dependent Changes of Insulin Sensitivity in Japanese Nondiabetic Subjects
Diabetes Care,
October 1, 2005;
28(10):
2590a - 2591a.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Barb, S. G. Wadhwa, J. Kratzsch, A. Gavrila, J. L. Chan, C. J. Williams, A. W. Karchmer, and C. S. Mantzoros
Circulating Resistin Levels Are Not Associated with Fat Redistribution, Insulin Resistance, or Metabolic Profile in Patients with the Highly Active Antiretroviral Therapy-Induced Metabolic Syndrome
J. Clin. Endocrinol. Metab.,
September 1, 2005;
90(9):
5324 - 5328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Bush, B. E. Darnell, R. A. Oster, M. I. Goran, and B. A. Gower
Adiponectin Is Lower Among African Americans and Is Independently Related to Insulin Sensitivity in Children and Adolescents
Diabetes,
September 1, 2005;
54(9):
2772 - 2778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Isobe, S. Saitoh, S. Takagi, H. Takeuchi, Y. Chiba, N. Katoh, and K. Shimamoto
Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study
Eur. J. Endocrinol.,
July 1, 2005;
153(1):
91 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saraheimo, C. Forsblom, J. Fagerudd, A.-M. Teppo, K. Pettersson-Fernholm, J. Frystyk, A. Flyvbjerg, P.-H. Groop, and on behalf of the FinnDiane Study Group
Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy
Diabetes Care,
June 1, 2005;
28(6):
1410 - 1414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Iwashima, T. Katsuya, K. Ishikawa, I. Kida, M. Ohishi, T. Horio, N. Ouchi, K. Ohashi, S. Kihara, T. Funahashi, et al.
Association of Hypoadiponectinemia With Smoking Habit in Men
Hypertension,
June 1, 2005;
45(6):
1094 - 1100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Xu, K. W. Chan, R. L. C. Hoo, Y. Wang, K. C. B. Tan, J. Zhang, B. Chen, M. C. Lam, C. Tse, G. J. S. Cooper, et al.
Testosterone Selectively Reduces the High Molecular Weight Form of Adiponectin by Inhibiting Its Secretion from Adipocytes
J. Biol. Chem.,
May 6, 2005;
280(18):
18073 - 18080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kadowaki and T. Yamauchi
Adiponectin and Adiponectin Receptors
Endocr. Rev.,
May 1, 2005;
26(3):
439 - 451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Fan, T. Yanase, M. Nomura, T. Okabe, K. Goto, T. Sato, H. Kawano, S. Kato, and H. Nawata
Androgen Receptor Null Male Mice Develop Late-Onset Obesity Caused by Decreased Energy Expenditure and Lipolytic Activity but Show Normal Insulin Sensitivity With High Adiponectin Secretion
Diabetes,
April 1, 2005;
54(4):
1000 - 1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang, R. I.G. Holt, S. H. Wild, R. B. Poole, H. Holt, and C. D. Byrne
Plasma Adiponectin Concentrations Are Independently Predicted by Fat Insulin Sensitivity in Women and by Muscle Insulin Sensitivity in Men
Diabetes Care,
March 1, 2005;
28(3):
755 - 756.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. Page, J. K. Amory, F. D. Bowman, B. D. Anawalt, A. M. Matsumoto, W. J. Bremner, and J. L. Tenover
Exogenous Testosterone (T) Alone or with Finasteride Increases Physical Performance, Grip Strength, and Lean Body Mass in Older Men with Low Serum T
J. Clin. Endocrinol. Metab.,
March 1, 2005;
90(3):
1502 - 1510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Maahs, L. G. Ogden, G. L. Kinney, P. Wadwa, J. K. Snell-Bergeon, D. Dabelea, J. E. Hokanson, J. Ehrlich, R. H. Eckel, and M. Rewers
Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification
Circulation,
February 15, 2005;
111(6):
747 - 753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. Page, K. L. Herbst, J. K. Amory, A. D. Coviello, B. D. Anawalt, A. M. Matsumoto, and W. J. Bremner
Testosterone Administration Suppresses Adiponectin Levels in Men
J Androl,
January 1, 2005;
26(1):
85 - 92.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rodriguez-Cuenca, M. Monjo, A. M. Proenza, and P. Roca
Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu
Am J Physiol Endocrinol Metab,
January 1, 2005;
288(1):
E200 - E207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S.-L. Lam, A. Xu, K. C.-B. Tan, L.-C. Wong, S.-C. Tiu, and S. Tam
Serum Adiponectin Is Reduced in Acromegaly and Normalized after Correction of Growth Hormone Excess
J. Clin. Endocrinol. Metab.,
November 1, 2004;
89(11):
5448 - 5453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kitazawa, T. Nishihara, T. Nambu, H. Nishizawa, M. Iwaki, A. Fukuhara, T. Kitamura, M. Matsuda, and I. Shimomura
Intectin, a Novel Small Intestine-specific Glycosylphosphatidylinositol-anchored Protein, Accelerates Apoptosis of Intestinal Epithelial Cells
J. Biol. Chem.,
October 8, 2004;
279(41):
42867 - 42874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Orio Jr., S. Palomba, T. Cascella, S. Di Biase, D. Labella, T. Russo, S. Savastano, F. Zullo, A. Colao, R. Vettor, et al.
Lack of an Association between Peroxisome Proliferator-Activated Receptor-{gamma} Gene Pro12Ala Polymorphism and Adiponectin Levels in the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
October 1, 2004;
89(10):
5110 - 5115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wakabayashi and Y. Aso
Adiponectin Concentrations in Sera From Patients With Type 2 Diabetes Are Negatively Associated With Sympathovagal Balance as Evaluated by Power Spectral Analysis of Heart Rate Variation
Diabetes Care,
October 1, 2004;
27(10):
2392 - 2397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ibanez, C. Valls, M. V. Marcos, K. Ong, D. B. Dunger, and F. de Zegher
Insulin Sensitization for Girls with Precocious Pubarche and with Risk for Polycystic Ovary Syndrome: Effects of Prepubertal Initiation and Postpubertal Discontinuation of Metformin Treatment
J. Clin. Endocrinol. Metab.,
September 1, 2004;
89(9):
4331 - 4337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ibanez, C. Valls, S. Cabre, and F. de Zegher
Flutamide-Metformin Plus Ethinylestradiol-Drospirenone for Lipolysis and Antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Early, Low-Dose Flutamide
J. Clin. Endocrinol. Metab.,
September 1, 2004;
89(9):
4716 - 4720.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|